186 related articles for article (PubMed ID: 17548632)
1. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
Abi-Rached L; Dorighi K; Norman PJ; Yawata M; Parham P
J Immunol; 2007 Jun; 178(12):7943-54. PubMed ID: 17548632
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
Ramsland PA; Willoughby N; Trist HM; Farrugia W; Hogarth PM; Fraser JD; Wines BD
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):15051-6. PubMed ID: 17848512
[TBL] [Abstract][Full Text] [Related]
3. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria.
Langley R; Wines B; Willoughby N; Basu I; Proft T; Fraser JD
J Immunol; 2005 Mar; 174(5):2926-33. PubMed ID: 15728504
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.
Wines BD; Ramsland PA; Trist HM; Gardam S; Brink R; Fraser JD; Hogarth PM
J Biol Chem; 2011 Sep; 286(38):33118-24. PubMed ID: 21784854
[TBL] [Abstract][Full Text] [Related]
5. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
Herr AB; Ballister ER; Bjorkman PJ
Nature; 2003 Jun; 423(6940):614-20. PubMed ID: 12768205
[TBL] [Abstract][Full Text] [Related]
6. FcαRI binding at the IgA1 C
Posgai MT; Tonddast-Navaei S; Jayasinghe M; Ibrahim GM; Stan G; Herr AB
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8882-E8891. PubMed ID: 30181292
[TBL] [Abstract][Full Text] [Related]
7. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster.
Wines BD; Sardjono CT; Trist HH; Lay CS; Hogarth PM
J Immunol; 2001 Feb; 166(3):1781-9. PubMed ID: 11160224
[TBL] [Abstract][Full Text] [Related]
8. FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.
van Egmond M; van Garderen E; van Spriel AB; Damen CA; van Amersfoort ES; van Zandbergen G; van Hattum J; Kuiper J; van de Winkel JG
Nat Med; 2000 Jun; 6(6):680-5. PubMed ID: 10835685
[TBL] [Abstract][Full Text] [Related]
9. A competitive mechanism for staphylococcal toxin SSL7 inhibiting the leukocyte IgA receptor, Fc alphaRI, is revealed by SSL7 binding at the C alpha2/C alpha3 interface of IgA.
Wines BD; Willoughby N; Fraser JD; Hogarth PM
J Biol Chem; 2006 Jan; 281(3):1389-93. PubMed ID: 16293625
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
Hellwig SM; van Spriel AB; Schellekens JF; Mooi FR; van de Winkel JG
Infect Immun; 2001 Aug; 69(8):4846-50. PubMed ID: 11447159
[TBL] [Abstract][Full Text] [Related]
11. The Fc receptor for IgA (FcalphaRI, CD89).
Otten MA; van Egmond M
Immunol Lett; 2004 Mar; 92(1-2):23-31. PubMed ID: 15081523
[TBL] [Abstract][Full Text] [Related]
12. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
Bakema JE; van Egmond M
Mucosal Immunol; 2011 Nov; 4(6):612-24. PubMed ID: 21937986
[TBL] [Abstract][Full Text] [Related]
13. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
Breedveld A; van Egmond M
Front Immunol; 2019; 10():553. PubMed ID: 30984170
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
Ben Mkaddem S; Rossato E; Heming N; Monteiro RC
Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
[TBL] [Abstract][Full Text] [Related]
15. Signaling through mutants of the IgA receptor CD89 and consequences for Fc receptor gamma-chain interaction.
Bakema JE; de Haij S; den Hartog-Jager CF; Bakker J; Vidarsson G; van Egmond M; van de Winkel JG; Leusen JH
J Immunol; 2006 Mar; 176(6):3603-10. PubMed ID: 16517729
[TBL] [Abstract][Full Text] [Related]
16. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
Aleyd E; Heineke MH; van Egmond M
Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
[TBL] [Abstract][Full Text] [Related]
17. Expression and correlation analysis of IL-4, IFN-γ and FcαRI in tonsillar mononuclear cells in patients with IgA nephropathy.
Chen X; Liu H; Peng Y; He L; Zhang Y; Xie Y; Peng X; Liu C; Liu F
Cell Immunol; 2014; 289(1-2):70-5. PubMed ID: 24732061
[TBL] [Abstract][Full Text] [Related]
18. Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.
Rogers KA; Jayashankar L; Scinicariello F; Attanasio R
J Immunol; 2008 Apr; 180(7):4816-24. PubMed ID: 18354205
[TBL] [Abstract][Full Text] [Related]
19. IgA Fc receptors.
Monteiro RC; Van De Winkel JG
Annu Rev Immunol; 2003; 21():177-204. PubMed ID: 12524384
[TBL] [Abstract][Full Text] [Related]
20. IgA and the IgA Fc receptor.
van Egmond M; Damen CA; van Spriel AB; Vidarsson G; van Garderen E; van de Winkel JG
Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
